Photo

Photo detail

Arie Belldegrun of Kite Pharma

Stories this photo appears in:

Gilead Sciences and Kite Pharma Acquire Cell Design Labs

Biotech giant Gilead Sciences Inc. and its Kite Pharma Inc. subsidiary in Santa Monica are buying Cell Design Labs Inc. for up to $567 million as the battle to develop cancer-targeting cell therapies heats up.

Tease photo

Deals & Dealmakers: Healthy Pharma Score

Kite boosts prognosis for L.A. action as Gilead puts $11.9 billion down for firm.

L.A.’s biotech industry has long occupied the No. 3 spot in the state rankings behind San Francisco and San Diego, but that doesn’t mean there aren’t deals to be had.

Tease photo